Lemtrada Long Term Side Effects

Side effects requiring immediate medical attention.

Lemtrada long term side effects.

Lemtrada side effect facts. The information is not intended to cover all possible uses directions precautions drug interactions or adverse effects nor should it be construed to indicate that use of a particular drug is. You take lemtrada as an intravenous infusion drip in two treatment courses twelve months apart. It reduces the number of relapses by about two thirds 70 compared to taking placebo.

Lemtrada can cause serious side effects including autoimmune problems infusion reactions stroke tears in your arteries that supply blood to your brain carotid and vertebral arteries some kinds of cancers thyroid problems low blood counts cytopenias inflammation of the liver hemophagocytic lymphohistiocytosis serious infections. General information about the safe and effective use of lemtrada. The european medicine agency ema has investigated some very rare side effects of this treatment read more about the safety review. These are not all the possible side effects of lemtrada.

Call your doctor for medical advice about side effects. Alemtuzumab is an infusion treatment for relapsing ms. Lemtrada is a disease modifying drug dmd for very active relapsing remitting ms. Common side effects include infusion related reactions which are generally mild and short lived and increased risk of.

Our lemtrada alemtuzumab side effects drug center provides a comprehensive view of available drug information on the potential side effects when taking this medication. Rash headache fever cold like symptoms nausea infection fatigue trouble sleeping black box warning autoimmunity infusion reactions stroke cancer. Call your doctor for medical advice about side effects. Along with its needed effects alemtuzumab the active ingredient contained in lemtrada may cause some unwanted effects.

Its brand name is lemtrada. You will need to have your blood work and urine checked while getting lemtrada alemtuzumab lemtrada and after getting it as you have been told by your doctor. Have evaluated additional findings about the immune system impacts of lemtrada alemtuzimab sanofi genzyme a disease modifying therapy for treating people with relapsing ms. Distribution restricted because of the risk of serious side effects the drug is only available through the lemtrada risk evaluation and mitigation strategy rems program.

You may report side effects to the fda at 1 800 fda 1088. This is not a complete list of side effects and others may occur. Who can take alemtuzumab. New research on lemtrada reveals insights into the cause of potential side effects june 13 2017 researchers in the u k.

Although not all of these side effects may occur if they do occur they may need medical attention. Side effects may happen while you get lemtrada alemtuzumab lemtrada and for 4 years after you stop treatment.